(Q54399520)

29 May 2018

title

High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India. (English)

1 reference

29 May 2018

main subject

India

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

pulmonary tuberculosis

1 reference

6

1 reference

29 May 2018

author name string

Parveen Kumar

1

1 reference

29 May 2018

Veena Balooni

2

1 reference

29 May 2018

Brijesh Kumar Sharma

3

1 reference

29 May 2018

Virender Kapil

4

1 reference

29 May 2018

K S Sachdeva

5

1 reference

29 May 2018

publication date

22 October 2013

1 reference

29 May 2018

published in

Tuberculosis

1 reference

29 May 2018

volume

94

1 reference

29 May 2018

page(s)

73-80

1 reference

29 May 2018

issue

1

1 reference

29 May 2018

Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Multiplex PCR assay for simultaneous detection and differentiation of Mycobacterium tuberculosis, Mycobacterium avium complexes and other Mycobacterial species directly from clinical specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Totally drug-resistant tuberculosis in India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.10.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2013.10.001

1 reference

29 May 2018

PubMed ID

24184256

1 reference

29 May 2018